Coriolis Pharma
Andrea Arsiccio is a Senior Scientist at Coriolis Pharma since April 2022, previously serving as a Scientist. Prior experience includes a Postdoctoral Researcher position at Politecnico di Torino and a Postdoctoral Scholar role at UCSB Department of Chemistry and Biochemistry. Andrea has also worked as a Visiting Scientist at the National Institute for Biological Standards and Control and performed Molecular Dynamics simulations of proteins as a Visiting Researcher at the University of California, Santa Barbara. As a PhD Student at Politecnico di Torino, responsibilities included tutoring courses on Numerical Analysis for Chemical Engineering and Control of Chemical Processes. Andrea holds a Bachelor's and Master's degree in Chemical Engineering from Politecnico di Torino and a scientific high school diploma from High school Charles Darwin in Rivoli, Torino.
Coriolis Pharma
2 followers
Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2. Formulation research and development (from pre-formulation to market formulations) Analytical method development (aggregate and particle characterization, protein analytics, GMP analytics) Forced degradation and stability testing (stress conditions tailored for the product, stability testing according ICH) Lyophilization (cycle development, scale up, modern PAT-tools) Supply of pre-clinical material (GMP-like conditions in clean room)